Aviva (LON:AV - Get Free Report)'s stock had its "overweight" rating reaffirmed by investment analysts at JPMorgan Chase & Co. in a research note issued to investors on Tuesday, Marketbeat reports. They presently have a GBX 615 ($7.77) price objective on the stock. JPMorgan Chase & Co.'s target price would indicate a potential upside of 23.99% from the stock's previous close.
Separately, Deutsche Bank Aktiengesellschaft restated a "top pick" rating on shares of Aviva in a research report on Friday, December 6th. Five investment analysts have rated the stock with a buy rating and one has issued a strong buy rating to the stock. Based on data from MarketBeat, the stock has an average rating of "Buy" and an average price target of GBX 579 ($7.32).
Check Out Our Latest Analysis on AV
Aviva Stock Performance
LON AV traded down GBX 0.10 ($0.00) during mid-day trading on Tuesday, reaching GBX 496 ($6.27). 16,045,979 shares of the stock were exchanged. Aviva has a 1 year low of GBX 390.70 ($4.94) and a 1 year high of GBX 510.20 ($6.45). The company has a debt-to-equity ratio of 68.87, a quick ratio of 1.57 and a current ratio of 2.93. The business's 50 day moving average is GBX 488.63 and its 200-day moving average is GBX 484.52. The company has a market capitalization of £13.33 billion, a P/E ratio of 10.22, a P/E/G ratio of 2.01 and a beta of 0.89.
Insiders Place Their Bets
In related news, insider Pippa Lambert acquired 988 shares of the firm's stock in a transaction on Friday, December 27th. The stock was bought at an average price of GBX 465 ($5.87) per share, for a total transaction of £4,594.20 ($5,804.42). Insiders own 0.17% of the company's stock.
Aviva Company Profile
(
Get Free Report)
Aviva plc provides various insurance, retirement, investment, and savings products in the United Kingdom, Ireland, Canada, and internationally. The company offers life insurance, long-term health and accident insurance, savings, pension, and annuity products, as well as pension fund business and lifetime mortgage products.
Featured Stories
Before you consider Aviva, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Aviva wasn't on the list.
While Aviva currently has a "Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Almost everyone loves strong dividend-paying stocks, but high yields can signal danger. Discover 20 high-yield dividend stocks paying an unsustainably large percentage of their earnings. Enter your email to get this report and avoid a high-yield dividend trap.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
